Form 4: NHC CEO Sells Shares, Exercises Options in Pre-Planned Trades
Insider Transaction Report
National Healthcare Corp's CEO, Stephen Flatt, reported selling 1,000 shares and exercising options for 1,853 shares as part of a Rule 10b5-1 plan.
Summary
- Stephen Fowler Flatt, CEO and Director of National Healthcare Corp (NHC), reported transactions involving the company's common stock.
- On November 21, 2025, Flatt disposed of 1,000 shares of common stock at a price of $130.33 per share.
- Following this sale, Flatt beneficially owned 59,130 shares of common stock directly.
- On November 25, 2025, Flatt acquired 1,853 shares of common stock by exercising stock options at a price of $53.94 per share.
- These stock options were granted on March 8, 2023, under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- After the option exercise, Flatt's direct beneficial ownership of common stock increased to 60,983 shares.
- The reported transactions were made pursuant to a Rule 10b5-1 pre-planned contract for the purchase or sale of equity securities.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive. While there was a sale of shares, it was part of a pre-planned 10b5-1 program, which reduces the negative signal. The CEO also exercised options to acquire a larger number of shares than sold, increasing his net direct beneficial ownership, which is generally a positive indicator of confidence.
Positives
- The CEO exercised options to acquire 1,853 shares of common stock, increasing his direct beneficial ownership by 853 shares net of the sale, indicating continued investment in the company.
- The option exercise price of $53.94 is significantly lower than the sale price of $130.33, suggesting a profitable transaction for the insider.
Negatives
- The CEO disposed of 1,000 shares of common stock, which could be interpreted as a reduction in direct exposure, although it was part of a pre-planned trading arrangement.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 03/08/2023 | Date stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan. |
| 03/08/2024 | Date exercisable for 8,000 stock options with an exercise price of $53.94. |
| 03/05/2025 | Date exercisable for 10,000 stock options with an exercise price of $94.1. |
| 11/21/2025 | Date of disposition of 1,000 shares of common stock. |
| 11/25/2025 | Date of exercise of 1,853 stock options and acquisition of common stock. |
| 02/28/2026 | Date exercisable for 18,000 stock options with an exercise price of $90.62. |
| 03/08/2028 | Expiration date for 8,000 stock options with an exercise price of $53.94. |
| 03/05/2029 | Expiration date for 10,000 stock options with an exercise price of $94.1. |
| 02/28/2030 | Expiration date for 18,000 stock options with an exercise price of $90.62. |
Keywords
National Healthcare Corp, NHC, Stephen Flatt, CEO, Director, Insider Trading, Form 4, Stock Options, Common Stock, Rule 10b5-1, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.